Health News Highlights: Stable Pig Prices, Investor Concerns, and Medical Developments

This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, and the withdrawal of Argentina from WHO after Trump's exit. Additionally, it discusses Novo Nordisk's response to potential tariffs, Boston Scientific's profit forecast, and new research on microplastics in the human brain.

German pig prices have remained stable amid growing hopes that a foot-and-mouth disease outbreak is now contained, according to the livestock and meat production association VEZG. The association reported unchanged slaughterhouse pig prices at 1.72 euros per kilo.

UnitedHealth is addressing concerns regarding Bill Ackman's controversial social media remarks with the U.S. Securities and Exchange Commission. The now-deleted post had alleged short positions against the healthcare giant, drawing significant attention from industry observers.

Amid strong quarterly results, AstraZeneca shareholders demand clarity regarding an ongoing investigation into executive Leon Wang by Chinese authorities. With AstraZeneca favoring stability in China—one of its crucial markets—the company seeks to address these uncertainties.

(With inputs from agencies.)